Starting Cancer Treatment at a Hospital with an Academic Approach Extends Survival

On 15 – 18 October 2017, Japan hosted the 18th World Conference on Lung Cancer. According to a study presented there, non-small cell lung cancer treatment begun at a center providing care from an academic perspective may extend patients’ overall survival.
The study used National Cancer Database records for 1.150.722 patients with non-small cell lung cancer. Patients starting their initial treatment at academic centers (%31.5) and nonacademic centers (%68.5) were divided into 2 groups.
The Study Produced Two Important Findings:
1) Among patients diagnosed between 2004 and 2009, median overall survival was 12.4 months, whereas among those diagnosed between 2010 and 2013, it was 14.8 months.
2) Patients starting treatment at centers providing care from an academic perspective had a lower risk of death; 4-year overall survival was %25 at academic centers and %19 at nonacademic centers.
In conclusion, this large study involving 1 and a half million patients shows that advances in cancer diagnosis and treatment and the experience of the center planning treatment are two factors directly affecting patients’ survival.
Sources
Survival trends among non-small cell lung cancer (NSCLC) patients over a decade: impact of initial therapy at academic centers.
International Association for the Study of Lung Cancer 18th World Conference on Lung Cancer; October 2017; Yokohama, Japan.
Was this article helpful?
Your feedback helps us improve our content.




Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.